Medicare Drug Price Negotiations: Selected Drugs for 2028
February 5, 2026
Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for
Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Comments on Proposed 2027 Medicare Advantage and Part D Policy Changes
January 26, 2026
A comprehensive commentary by the Medicare Rights Center on the Centers for Medicare & Medicaid Services (CMS) proposed rule for
Lowering Part D Costs: Federal, State, and Local Options
January 21, 2026
Extra Help The main federal program that provides Part D cost assistance is Extra Help, and many people enrolled in other cost-saving programs receive Extra Help coverage
Understanding Medicare Part D and Prescription Drug Coverage
January 14, 2026
This month, the Medicare Rights Center, with the support of the National Council on Aging, is releasing a new series of videos explaining Medicare benefits and
Reconciliation Bill More Harmful and Costly Than Previously Thought
October 23, 2025
This week, the nonpartisan Congressional Budget Office (CBO) said a provision in the reconciliation bill that widens exemptions from Medicare’s
Negotiated Prices Take Effect for Ten Drugs in 2026
October 9, 2025
The Inflation Reduction Act (IRA) of 2022 created a new ability for Medicare to negotiate prices for the most expensive
Part D Benefit Restructuring Reduces Out-Of-Pocket Exposure, Changes Risk to Prescription Coverage Access and Choice
July 17, 2025
Prescription drug coverage in Medicare, provided via private health insurance plans under Part D, covers more than 53 million Americans.
New Research Confirms Importance of Drug Affordability and Low Out-of-Pocket Costs
April 24, 2025
As we have highlighted in past articles, many people with Medicare—and many callers to our national consumer helpline—struggle to afford
Drug Pricing Executive Order Boosts Pharmaceutical Industry’s Goals
April 17, 2025
On Tuesday, President Trump issued an executive order on prescription drug pricing that supports key drug industry efforts to weaken
Medicare Drug Price Negotiations: Selected Drugs for 2028
February 5, 2026
Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for
Comments on Proposed 2027 Medicare Advantage and Part D Policy Changes
January 26, 2026
A comprehensive commentary by the Medicare Rights Center on the Centers for Medicare & Medicaid Services (CMS) proposed rule for
Lowering Part D Costs: Federal, State, and Local Options
January 21, 2026
Extra Help The main federal program that provides Part D cost assistance is Extra Help, and many people enrolled in other cost-saving programs receive Extra Help coverage
Understanding Medicare Part D and Prescription Drug Coverage
January 14, 2026
This month, the Medicare Rights Center, with the support of the National Council on Aging, is releasing a new series of videos explaining Medicare benefits and
Reconciliation Bill More Harmful and Costly Than Previously Thought
October 23, 2025
This week, the nonpartisan Congressional Budget Office (CBO) said a provision in the reconciliation bill that widens exemptions from Medicare’s
Negotiated Prices Take Effect for Ten Drugs in 2026
October 9, 2025
The Inflation Reduction Act (IRA) of 2022 created a new ability for Medicare to negotiate prices for the most expensive
Part D Benefit Restructuring Reduces Out-Of-Pocket Exposure, Changes Risk to Prescription Coverage Access and Choice
July 17, 2025
Prescription drug coverage in Medicare, provided via private health insurance plans under Part D, covers more than 53 million Americans.
New Research Confirms Importance of Drug Affordability and Low Out-of-Pocket Costs
April 24, 2025
As we have highlighted in past articles, many people with Medicare—and many callers to our national consumer helpline—struggle to afford
Drug Pricing Executive Order Boosts Pharmaceutical Industry’s Goals
April 17, 2025
On Tuesday, President Trump issued an executive order on prescription drug pricing that supports key drug industry efforts to weaken